| Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
 Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
  
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
 Warning:  file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=14707282&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
 in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
 
   English Wikipedia
 
 Nephropedia Template TP (
 
 Twit Text
 
 
 DeepDyve
 Pubget Overpricing
 | lüll   
 
 MDM2, an introduction Iwakuma T; Lozano GMol Cancer Res  2003[Dec]; 1 (14): 993-1000The murine double minute 2 (mdm2) gene encodes a negative regulator of the p53  tumor suppressor. Amplification of mdm2 or increased expression by unknown  mechanisms occurs in many tumors. Thus, increased levels of MDM2 would inactivate  the apoptotic and cell cycle arrest functions of p53, as do deletion or mutation  of p53, common events in the genesis of many kinds of tumors. MDM2 functions as  an E3 ubiquitin ligase to degrade p53. MDM2 also binds another tumor suppressor,  ARF. This interaction sequesters MDM2 in the nucleolus away from p53, thus  activating p53. Many additional MDM2 interacting proteins have been identified.  Functions of MDM2 independent of p53 have also been identified. This article is  an introduction to MDM2, its structure and biological functions, as well as its  relationship to its binding partners.|Animals[MESH]|Gene Expression Regulation[MESH]|Humans[MESH]|Nuclear Proteins/*physiology[MESH]|Proto-Oncogene Proteins c-mdm2[MESH]|Proto-Oncogene Proteins/*physiology[MESH]|Signal Transduction[MESH]|Tumor Suppressor Protein p53/metabolism[MESH]
 |